MedBridge Shanghai · International medical facilitation platform recognized under Shanghai Government Document No. 32
Back to home
West China Hospital, Sichuan University

Grade III-A · National Comprehensive Medical Center

West China Hospital, Sichuan University

Lung cancerEsophageal cancerLiver cancerBrain tumor

Established

1892

Beds

4,300+

Annual Volume

5,000,000+

Chengdu

The leading medical hub of Western China with top-tier comprehensive cancer care and translational research.

About the Hospital

West China Hospital of Sichuan University is the national center for complex and critical care in western China, ranking second nationally in the Fudan comprehensive hospital ranking for many consecutive years. Its cancer center leverages the hospital’s comprehensive strength, excelling in multidisciplinary collaboration and comorbidity management for complex tumors.

West China leads nationally in minimally invasive surgery, precision radiotherapy and translational research for lung, esophageal, head-neck and abdominal tumors, and is one of the National Clinical Research Centers for Cancer.

Hospital Strengths

01Comprehensive strength for complex cases

Cancer patients with cardiopulmonary disease, diabetes and other comorbidities receive hospital-wide MDT support, with nationally leading perioperative safety.

02Largest radiotherapy center in western China

Equipped with multiple linacs, TOMO and brachytherapy systems, it treats the largest annual radiotherapy volume in western China.

03The western hub for clinical research

As a national drug clinical-trial institution, it hosts numerous international multicenter studies and is the main gateway for western-China patients to frontier research.

Key Departments

Thoracic OncologyAbdominal OncologyHead & Neck OncologyBreast SurgeryMedical OncologyRadiation Oncology

Coordinated Treatment Directions

  1. 01Minimally invasive lung surgery and comprehensive care
  2. 02Esophageal cancer continuum and minimally invasive surgery
  3. 03MDT management of cancer patients with comorbidities
  4. 04Abdominal tumor care and translational research

Officially Reported Treatment Milestones

Cell-therapy translation platform of the State Key Laboratory of Biotherapy

2016–

Relying on the State Key Laboratory of Biotherapy, it conducts CAR-T and cancer vaccine research, forming the largest tumor biotherapy R&D base in western China.

Exporting institution of the national regional cancer care center

2019–

As an exporting hospital of the national regional cancer care center, it exports technology and management to western provinces, building a specialty alliance and two-way referral network covering the region.

Accreditations & Platforms

  • National Comprehensive Medical Center (first batch)
  • Ranked No.2 nationally in the Fudan hospital ranking for consecutive years